C07H 19/09
With arabinosyl as the saccharide radical
Official title: with arabinosyl as the saccharide radical
C07H19/09 (With arabinosyl as the saccharide radical) appears on 25 US grants and 42 published applications in this corpus.
Search patents in C07H- Granted patents
- 25
- Published applications
- 42
- Assignees
- 29
- Inventors
- 140
- Latest grant
- 7 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 0 | 1 |
| 2005 | 0 | 1 |
| 2006 | 1 | 1 |
| 2007 | 0 | 1 |
| 2008 | 1 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 1 |
| 2011 | 2 | 1 |
| 2012 | 0 | 7 |
| 2013 | 0 | 2 |
| 2014 | 6 | 2 |
| 2015 | 1 | 3 |
| 2016 | 1 | 2 |
| 2017 | 1 | 0 |
| 2018 | 1 | 2 |
| 2019 | 0 | 2 |
| 2020 | 1 | 2 |
| 2021 | 2 | 4 |
| 2022 | 2 | 2 |
| 2023 | 1 | 3 |
| 2024 | 2 | 2 |
| 2025 | 1 | 2 |
| 2026 | 2 | 0 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Phosphoramidates for the treatment of hepatitis B virus7 Apr 2026US 12,595,280 B2Emory University
- Oligonucleotide compositions and methods of use thereof17 Feb 2026US 12,552,743 B2Wave Life Sciences Ltd.
- Therapeutic oligonucleotides26 Aug 2025US 12,398,172 B2Caris Science, Inc.
- Salts of conjugates for cancer therapy27 Aug 2024US 12,071,450 B2Biosight Ltd.
- Phosphoramidates for the treatment of hepatitis B virus14 May 2024US 11,981,699 B2Emory University
- Therapeutic agent for blood cancer2 Oct 2025US 2025/0304612 A1Aptabio Therapeutics Inc.
- Nucleotides with enzymatically cleavable 3'-o-glycoside blocking groups for sequencing3 Jul 2025US 2025/0215493 A1
- Phosphoramidates for the treatment of hepatitis b virus19 Sep 2024US 2024/0309039 A1Emory University
- Therapeutic oligonucleotides2 May 2024US 2024/0140978 A1Caris Science, Inc.
- Synthesis of [18f]-labeled thymidine analogues28 Dec 2023US 2023/0416293 A1University of Southern California
Most cited
By later US patents
- Azido nucleosides and nucleotide analogs59US 8,877,731 B2Alios BioPharma, Inc. · 2014
- 1′-substituted pyrimidine N-nucleoside analogs for antiviral treatment52US 8,877,733 B2Gilead Sciences, Inc. · 2014
- Double-liver-targeting phosphoramidate and phosphonoamidate prodrugs18US 9,156,874 B2Nanjing Molecular Research, Inc. · 2015
- L-nucleic acid derivatives and process for the synthesis thereof12US 7,125,983 B2Mitsui Chemicals, Inc. · 2006
- Azido nucleosides and nucleotide analogs11US 9,346,848 B2Alios BioPharma, Inc. · 2016